Treatment of PC3 prostate cancer cells with mitoxantrone, etoposide, doxorubicin and carboplatin induces distinct alterations in the expression of kallikreins 5 and 11. (Q50454454)
Jump to navigation
Jump to search
scientific article published in February 2009
- Treatment of PC3 prostate cancer cells with mitoxantrone, etoposide, doxorubicin and carboplatin induces distinct alterations in the expression of kallikreins 5 and 11
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of PC3 prostate cancer cells with mitoxantrone, etoposide, doxorubicin and carboplatin induces distinct alterations in the expression of kallikreins 5 and 11. |
scientific article published in February 2009 |
|
Statements
1 reference
Treatment of PC3 prostate cancer cells with mitoxantrone, etoposide, doxorubicin and carboplatin induces distinct alterations in the expression of kallikreins 5 and 11. (English)
1 reference
Treatment of PC3 prostate cancer cells with mitoxantrone, etoposide, doxorubicin and carboplatin induces distinct alterations in the expression of kallikreins 5 and 11 (English)
0 references
1 reference
Hellinida Thomadaki
1 reference
Konstantinos Mavridis
1 reference
Andreas Scorilas
1 reference
1 February 2009
1 reference
2009
0 references
101
1 reference
2
1 reference
02
0 references
373-380
1 reference
Identifiers
1 reference